Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.36 USD | -2.06% | +11.91% | +183.26% |
May. 09 | Q32 Bio Inc. Provides Corporate Update | CI |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+183.26% | 370M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Transcript : Homology Medicines, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 through May-16-2019